StayAlert Results:
Search results for: "fda"
362 results (showing 1 through 25)
The US Food and Drug Administration (FDA) has issued a safety communication to alert health care providers and patients about cybersecurity vulnerabilities ...
The US Food and Drug Administration (FDA) is alerting health care professionals , oncology clinical investigators and patients about the risks associated with the ...
According to the FDA: * Medications containing only amlodipine or hydrochlorothiazide (HCTZ) are not being recalled. Manufacturers are recalling medications ...
The US Food and Drug Administration (FDA) has issued warning letters to two breast implant manufacturers for failure to comply with their requirements, under ...
... this product may be reported to the FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2019 Medical Product Safety Alert.
... (mailto:FieldActionsNA@CookMedical.com) Follow the link below for additional information. Resources: * External Links * FDA 2019 Medical Product Safety ...
... this product may be reported to the FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2019 Medical Product Safety Alert.
... MedWatch Adverse Event Reporting program Follow the link below for additional information. Resources: * External Links * FDA 2019 Medical Product Safety ...
The US Food and Drug Administration (FDA) notified health care providers several weeks ago about the potential for increased long-term mortality after use of ...
The US Food and Drug Administration (FDA) has issued a Letter to Health Care Providers alerting them to the increasing number of adverse events associated ...
... this product may be reported to the FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2019 Medical Product Safety Alert.
The US Food and Drug Administration (FDA) is reminding users of the Zoll LifeVest 4000 to contact the manufacturer immediately for a replacement device if ...
The FDA has classified this as a Class I Recall, the most serious type of recall. Use of these devices may cause serious injuries or death. On October 23, 2018, ...
... this product may be reported to the FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2019 Medical Product Safety Alert.
... this product may be reported to the FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2019 Medical Product Safety Alert.
Hetero Labs Ltd. in India has announced a recall of 87 lots of losartan potassium tablets (https://www.fda.gov/Safety/Recalls/ucm632395.htm) (25 mg, 50 mg and ...
According the FDA, there is limited, preliminary evidence that the use of robotically-assisted surgical devices for treatment or prevention of cancers that primarily ...
The US Food and Drug Administration (FDA) has classified this a Class I Recall, the most serious type of recall. Use of these devices may cause serious injuries ...
The US Food and Drug Administration (FDA) is alerting the public that a safety clinical trial found an increased risk of blood clots in the lungs and death when a ...
... of this product may be reported to FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2019 Medical Product Safety Alert.
The US Food and Drug Administration (FDA) has issued a Safety Communication alerting women, health care providers, and people getting breast cancer ...
The US Food and Drug Administration (FDA) has concluded there is an increased risk of death with Uloric (febuxostat) compared to another gout medicine, ...
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety ...
The US Food and Drug Administration (FDA) has recently become aware of reports of establishments in several states that are offering infusions of plasma from ...
... three attempts to notify them is obtained. Follow the link below for additional information. Resources: * External Links * FDA 2019 Medical Product Safety Alert .
Previous Page Next Page